9305-9954 Quebec Inc Report issue

For profit Phase 2 Phase 3
Founded: Quebec Canada (2014)
Status: No NME R&D (2014)

Organization Overview

First Clinical Trial
2015
NCT02232256
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now